To advance scientific knowledge and develop treatments and cures for breast cancer, the Extramural Grants Administration Program staff will issue requests for applications on behalf of the NYS Health Research Science Board. Check this web site for updates or sign up for HRSB eAlerts and indicate Request for Applications (RFA) as your area of interest.

Click here for tips on managing graphics and file sizes submitted with your RFA or RFP.

Funding Opportunities Pending Review

  • Healthcare Practitioner Breast Cancer Education Research Projects (Round 4) RFA
  • Peter T. Rowley Breast Cancer Scientific Research Projects (Round 7) RFA

  • Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects (Round 8) RFA

Recent Awards

  • Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 6).  These projects are two-year awards. 
Principal Investigator Institution Amount Title

Brian Brown, Ph.D.

Icahn School of Medicine at Mount Sinai $360,000

Identifying Regulators of Breast Cancer Immunity Through Pro-Code/CRISPR Genomics

Angel T. Chan, M.D., Ph.D.
 

Sloan Kettering Institute for Cancer Research $360,000 Trastuzumab-Induced Cardiotoxicity: Genomic and Cellular Signatures in Patient Specific Induced Pluripotent Stem Cell-derived Cardiomyocytes from Breast Cancer Survivors

Gregory David, Ph.D.

New York University School of Medicine

$360,000 Targeting the Senescence-Associated Secretory Phenotype as an Adjuvant Therapy to Prevent Breast Cancer Progression
Amr Ghaleb, Ph.D.
 
Stony Brook University

$312,112

Centrosome Clustering as a Survival Mechanism Driven by Mutant p53 in Breast Cancer

Hanna Y. Irie, M.D., Ph.D.

Icahn School of Medicine at Mount Sinai

$359,846

A Novel Approach to Overcoming Endocrine Therapy Resistance of ER+ Breast Cancer Cells 

Jose Silva, Ph.D.

Icahn School of Medicine at Mount Sinai $360,000 Dissecting the Role of miR-424(322)/503 in Stem Cell Control and Pregnancy Associated Tumors

Jamilia R. Sly, Ph.D.

Icahn School of Medicine at Mount Sinai $360,000 Developing a Culturally Adapted Education Program to Increase African Immigrants' Breast Cancer Screening
Brent R. Stockwell, Ph.D. Columbia University  $359,453  Discovery of Ferroptosis Inducers Targeting CoQ10-Dependent Breast Cancers
  • Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects RFA (Round 7). Although, no awards were recommended for funding this RFA, the HRSB recommended more meritorious Rowley Round 6 awards than originally anticipated.
  • Healthcare Practitioner Breast Cancer Education Research Projects RFA (Round 3). Although, no applications were received for this RFA, the HRSB recommended more meritorious Rowley Round 6 awards than originally anticipated.
  • Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 5). These projects are two-year awards.
Principal Investigator Institution Amount Title

Piero D. Dalerba, M.D.

Columbia University $359,899 A Novel Biomarker to Improve Risk-Prediction in Familial Breast Cancer Patients
David Entenberg, Ph.D. Albert Einstein College of Medicine, Inc. $360,000 Direct Visualization of Physiologically Relevant Metastasis Using Surgical and Optical Engineering
Heather Ochs-Balcom, Ph.D. University at Buffalo $343,354 The Association Between Follicle Stimulating Hormone, Obesity, and Breast Cancer in Postmenopausal Women

Maja Oktay, M.D., Ph.D.

Albert Einstein College of Medicine, Inc. $360,000

Racial Disparity in Pro-Metastatic Breast Cancer Microenvironment and Response to Chemotherapy

Zhenqiang Yao, M.D., Ph.D.

University of Rochester $338,741 Elimination of Breast Cancer Metastasis by Killing Cancer Cells and Interfering in the Host Environment
  • Healthcare Practitioner Breast Cancer Education Research Projects RFA (Round 2). These projects are three-year awards.
Investigators Institutions Amount Title

Victoria H. Raveis, Ph.D.,

Jacqueline Reinhard, M.Ed., and

Simona Kwon, Dr.P.H.
New York University partnering with SHARE: Self Help for Women with Breast or Ovarian Cancer & NYU School of Medicine $260,493 Developing a Patient-Centered Curriculum for Primary Care Practitioners to Enhance Breast Cancer Survivorship Care that Informs and Engages Diverse Breast Cancer Survivors

Elizabeth H. Ruder, Ph.D., M.P.H. and

Holly Anderson, B.S., R.N.
Rochester Institute of Technology partnering with Breast Cancer Coalition of Rochester

$268,334

PAMI: Physician Assistant Motivational Inverviewing and Health Literacy to Enhance Health in Breast Cancer Survivors
  • Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects RFA (Round 6). This project is a three-year award. 
Investigators Institutions Amount Title

Laurene M. Tumiel-Berhalter, Ph.D. and

Charise Walker-Betts, B.S.W.
University at Buffalo partnering with Our Curls, Inc. $270,000

You cannot change your family history, but you can change what you do with it: A peer-based education program to reduce breast cancer risk in African American women

  • Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 4). These projects are two-year awards.
Principal Investigator Institution Amount Title

Scott A. Coonrod, Ph.D.

Cornell University $358,832 Histone Citrullination in Estrogen Receptor Signaling and Breast Cancer
Jo L. Feudenheim, Ph.D. University at Buffalo $359,024 The Microbiome in the Etiology and Prevention of Breast Cancer

Jun Lin, M.D., Ph.D.

Stony Brook University $360,000 Effects of Anesthetics on Lung Metastasis in Mouse Models of Breast Cancer
Cristina Montagna, Ph.D. Albert Einstein College of Medicine $360,000 Somatic Mutation Rate in Mammary Epithelial Cells and Peripheral B-Lymphocytes as Risk Factor for Breast Cancer

Harry Ostrer, M.D.

Albert Einstein College of Medicine $326,910 High Throughput Functional Genomics to Guide Precision Care
Jonathan C. Pertruccelli, Ph.D., University at Albany $335,905 A Simultaneous Phase and Scatter Imaging Towards a Clinical System for Early-Stage Breast Cancer Diagnosis
Jose Silva, Ph.D. Icahn School of Medicine at Mount Sinai $360,000 Sensing Cell Geometry: A Novel Checkpoint Critical for Breast Tumor Suppression
  • Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects RFA (Round 5). These projects are three-year awards.
Principal Investigator Institution Amount Title
Lina Jandorf, M.A. Icahn School of Medicine at Mount Sinai $268,599 Development of an Intergenerational Breast Health Community Education Program for Black Women: Reducing the Risk for Triple Negative Breast Cancer in Black Women through Breastfeeding
Jin Young Seo, Ph.D. The Research Foundation of CUNY, Hunter College $245,002 A Culturally Tailored Education Program to Reduce Breast Cancer Risk in Korean Immigrant Women
  • Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 3). These projects are two-year awards.
Principal Investigator Institution Amount Title
Chia-Hsin Chan, Ph.D. The Research Foundation for SUNY Stony Brook $359,999 A New Strategy and Tool to Tackle Cancer Stem Cells and Metastasis in Triple-negative Breast Cancer

Mikala Egeblad, Ph.D.

Cold Spring Harbor Laboratory $345,800 Modulating Innate-adaptive Immune Cell Interactions for the Immunotherapy of Breast Cancer
Sharon S. Evans, Ph.D. Health Research Incorporated, Roswell Park Cancer Institute $360,000 Novel Mechanism of Immune Subversion by Myeloid-Derived Suppressor Cells in Aggressive Breast Cancer
John G. Frelinger, Ph.D. University of Rochester $357,747 Amplifying Immune Responses to Breast Cancer Using a Novel IL.2 Therapy to Limit Side Effects and Enhance Efficacy
David Jeruzalmi, Ph.D. The Research Foundation of CUNY obo City College of New York $347,200 Laying the Foundation for Combination Therapy Against Breast Cancer: Analysis of Human Shelterin-DNA Complex
Mira Krendel, Ph.D. The Research Foundation for SUNY Upstate Medical University $360,000 Myosin 1e as a Potential Therapeutic Target in Breast Cancer
Juntao Luo, Ph.D. State University of New York Upstate Medical University $360,000 Structure-based Nanocarrier Design for Targeted Cabazitaxel Delivery to the Advanced Breast Cancer Brain Metastases
Mark Noble, Ph.D. University of Rochester $359,907 Safer and More Effective Treatment of Luminal Breast Cancer and Overcoming Tamoxifen Resistance

Scott Powers, Ph.D.

The Research Foundation for SUNY Stony Brook $350,302 Single-cell Barcoding to Study Breast Cancer Evolution and Drug Resistance

Robert J. Schneider, Ph.D.

New York University School of Medicine $360,000 Reversing Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
  • Peter T. Rowley Breast Cancer Research Project and Postdoctoral Fellowship Awards RFA (Round 2): A total of $3,597,800 million in Peter T. Rowley Breast Cancer Research Project and Postdoctoral Fellowship Awards RFA awards were made in 2011, providing initial support for preliminary testing of novel or exploratory hypotheses related to breast cancer. Recipients are expected to open a new area of investigation, satisfactorily test a novel hypothesis, or produce viable data for preparation of a full-scale research application to another organization. Awards were made to eight investigators, with a maximum of $360,000 for two-year projects. 
Principal Investigator Institution Amount  Title
Anne R. Bresnick, Ph.D. Albert Einstein College of Medicine $360,000 Stromal Contribution of the S100A4 Metastasis Factor to Tumor Invasion
Pamela Cowin, Ph.D. New York University School of Medicine $360,000 The Role of Gpr 125 in Breast Development and Cancer
Johanna A. Joyce, Ph.D. Sloan-Kettering Institute for Cancer Research $360,000 Investigating and Targeting Interactions Between Cancer and the Microenvironment in Breast to Brain Metastasis
Paraic A. Kenny, Ph.D. Albert Einstein College of Medicine $360,000 Consequences of GATA3 Mutation for Normal Mammary Gland Development and Breast Cancer
Xiaojing Ma, Ph.D. Weill Cornell Medical College $360,000 Targeting CCL5 in Triple Negative Breast Cancer
Jeffrey W. Pollard, Ph.D. Albert Einstein College of Medicine $360,000 Macrophages and Immunosuppression in Breast Cancer
Elizabeth A. Repasky, Ph.D. Roswell Park Cancer Institute $357,000 Is the Immune Response Against Breast Cancer Inhibited by Lack of Available Metabolic Energy?
Rodney Rothstein, Ph.D. Columbia University $360,000 Developing a New Paradigm to Discover Novel Breast Cancer Drug Targets